RNCOS report "US Biotech Market Analysis” provides an updated and detailed overview of the U.S Biotechnology industry. It examines the emerging trends and provides exclusive forecasts, segment wise snapshots of biotechnology industry in U.S.
Key Findings
- Growing at the rate of 13.95% from the year 2005, U.S Biotechnology industry is expected to touch the mark of US$ 131.8 Billion by the end of 2010.
- Biotechnology will play an important role in Agricultural sector by developing large number of genetically modified seeds.
- The biomedical sector accounts for the major share of overall biotech industry in US and will continue to dominate in future as well.
- The clinical trial industry will cross US$ 30 Billion mark by 2011.
Key Issues and Facts Analyzed
The research report also addresses the issues and facts that are critical to your success:
- Major market trends in the US Biotechnology industry?
- Where will the market be after 5 years?
- What opportunities exist in US Biotechnology industry?
- What are the driving factors for the US Biotechnology industry?
- Challenges faced by Biotechnology industry?
- Who are the main players in the US Biotechnology industry?
Key Players Analyzed
This section provides the overview, key facts financial information of prominent players in the Indian Biotechnology Industry like Chiron Corporation, Amgen Inc., Biogen Idec Inc., Applied Biosystems, Genentech, and Baxter International Inc.
Research Methodology Used
Information Sources
Information has been sourced from namely, books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to access to more than 3000 paid databases.
Analysis Methods
The analysis methods include the following: Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis using software tools, Judgmental Forecasting and Cause and Effect Analysis.
